Viewing Study NCT04960618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-01-31 @ 4:20 AM
Study NCT ID: NCT04960618
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2021-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mycosis Fungoides View
None Mycosis Fungoides/Sezary Syndrome View
None Sezary Syndrome View
None Sézary View
None Advanced Mycosis Fungoides View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced Mycosis Fungoides View
None Mycosis Fungoides View
None Sezary Syndrome View
None 21-242 View
None Memorial Sloan Kettering Cancer Center View